Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-20-001966

Options or other derivatives

  • Director acquired 46,559 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Evans Carl Anthony · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-12 Grant or award : show line 1 in the form Option to purchase common stock +46,559 146,559 D
Loading xslF345X03/ownership.xml…